Metraipolis › archive › dc_cd448536a80b

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting — Europe PMC PMID:42465546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42465546
DOI
10.3389/fneur.2026.1882884
License (as archived)
solo-consultazione
Archived
2026-10-07T19:38:14.754Z
SHA-256 of the archived text
5e6644f6d6c76cccc6eaa87830b57cacac9b5da8f3bcaa78bc7a75ddfc62a892
Stable URL of this page
https://metraipolis.com/documento/dc_cd448536a80b

How to cite

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting — Europe PMC PMID:42465546 — Europe PMC (en), https://europepmc.org/article/MED/42465546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd448536a80b (Metraipolis archive dc_cd448536a80b, sha256 5e6644f6d6c76cccc6eaa87830b57cacac9b5da8f3bcaa78bc7a75ddfc62a892)
BibTeX
@misc{dccd448536a80b,
  title = {Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting — Europe PMC PMID:42465546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42465546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd448536a80b; sha256 5e6644f6d6c76cccc6eaa87830b57cacac9b5da8f3bcaa78bc7a75ddfc62a892},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42465546. Agents can read the archived copy with the MCP tool read_document.